Y-mAbs Therapeutics

Patent cliffs & loss of exclusivity

Antibody Therapies for Oncology

Company

Legal NameY-mAbs Therapeutics, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/y-mabs-therapeutics
Full AddressAgern Allé 11, ground floor 2970 Hørsholm Denmark
LinkedIn URLhttps://www.linkedin.com/company/y-mabs-therapeutics-inc-/
Pitchbook URLhttps://pitchbook.com/profiles/company/221665-33#overview
Seedtable URLhttps://seedtable.com/companies/y-mabs-therapeutics
Stock SymbolYMAB

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. Danyelzanaxitamab-gqgkBiologicNov 2032

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Y-mAbs Therapeutics — patent cliffs & loss of exclusivity | CliffBio